Summary by Moomoo AI
Novartis AG has submitted its Annual Report 2024 and Novartis in Society - Integrated Report 2024 to the U.S. Securities and Exchange Commission on January 31, 2025. These comprehensive reports provide detailed insights into the company's financial performance, operational achievements, and sustainability initiatives for the fiscal year 2024.The filing, completed under Form 6-K as a foreign private issuer, demonstrates Novartis's commitment to maintaining transparent communication with investors and regulatory compliance with U.S. securities laws. The reports were officially signed by Paul Penepent, Head of Financial Reporting and Accounting.
Comment(0)
Reason For Report